Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

Objectives. To evaluate the risk of serious infections (SIs) in patients with RA treated with anti-TNF therapy with emphasis on the risk across different ages. Methods. Using data from the British Society for Rheumatology Biologics Register, a prospective observational study, we compared the risk of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Galloway, James B., Hyrich, Kimme L., Mercer, Louise K., Dixon, William G., Fu, Bo, Ustianowski, Andrew P., Watson, Kath D., Lunt, Mark, Symmons, Deborah P. M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2011
Gaiak:
Clinical Science
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3105607/
https://ncbi.nlm.nih.gov/pubmed/20675706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keq242
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak